ANI Pharmaceuticals, Inc. (ANIP)

Last Closing Price: 75.22 (2026-03-02)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

ANI Pharmaceuticals, Inc. (ANIP) had Net Income of $77.18M for the most recently reported fiscal year, ending 2025-12-31.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
$883.37M
Net Income
$77.18M
$341.31M
$542.06M
$772.27M
$111.09M
$-15.30M
$95.79M
$95.79M
$78.34M
$78.34M
$78.34M
$78.34M
$111.09M
$202.51M
20.05M
21.23M
$3.50
$3.32
Balance Sheet Financials
$753.12M
$62.48M
$687.26M
$1.44B
$278.11M
$599.77M
$621.54M
$899.65M
$540.72M
$-1.28M
$540.72M
22.50M
Cash Flow Statement Financials
$185.22M
$-34.32M
$-9.94M
$144.89M
$285.62M
$140.73M
$37.93M
--
$-1.16M
Fundamental Metrics & Ratios
2.71
--
--
0.53
1.14
61.36%
12.58%
12.58%
22.92%
10.84%
8.74%
$171.39M
--
--
--
0.61
2.39
3.14
116.14
14.49%
-6110.32%
5.44%
6.87%
$24.03
$8.07
$8.73